Published in Pharma Investments, Ventures and Law Weekly, December 18th, 2005
The company also reported several clinical and operational achievements during the quarter ended September 30, 2005, including:
1) The expansion of the U.S. phase I/II clinical trial of the company's adult stem cell-based Tissue Repair Cells (TRCs) in the treatment of severe long bone open or non-union fractures to include the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska. UNMC is the fifth site engaged in this U.S. multicenter trial, which is currently underway at Lutheran General Hospital, Park Ridge,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.